CYSTIC FLUID FOR ADA

This study conducted by Hypro Diagnostics offers a thorough examination of adenosine deaminase (ADA) levels in ascitic fluid, serving as a pivotal diagnostic tool for peritoneal tuberculosis (PTB). Through a meticulous systematic review and meta-analysis involving 264 patients across 12 prospective studies, the study establishes the robustness of ADA levels. With an impressive sensitivity of 100% and specificity of 97%, particularly highlighting a defined cut-off point at 39 IU/L, these findings present a significant advancement. The emphasis on employing the Giusti method for ADA determination adds a layer of standardization. This research not only affirms ADA as a prompt and precise diagnostic test for PTB but also introduces a standardized approach with a specific cut-off value, enhancing its clinical applicability. Hypro Diagnostics’ work has the potential to redefine the diagnostic landscape for PTB, offering clarity and precision in a challenging clinical context.